Insmed (INSM) Interest Coverage Ratio (2011 - 2026)
Insmed (INSM) posted quarterly Interest Coverage Ratio of 7.63 for Q1 2026, up 33.64% year-over-year from 5.71 in Q1 2025, and down 150.54% quarter-over-quarter from 15.11 in Q4 2025.
Insmed (INSM) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
Insmed's Interest Coverage Ratio history runs 16 years deep, the most recent figure standing at 7.63 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 33.64% year-over-year to 7.63; the TTM figure through Mar 2026 stood at 28.41 (down 147.5% YoY), while the FY2025 annual figure was 0.86, down 9.67% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 7.63, down from 15.11 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 15.11 in Q4 2025, with the low at 38.08 in Q3 2022.
- The 5-year median for Interest Coverage Ratio is 11.42 (2023), against an average of 13.32.
- The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio slumped 313.31% in 2022, then surged 241.28% in 2025.
- Insmed's Interest Coverage Ratio stood at 9.21 in 2022, then tumbled by 132.46% to 21.41 in 2023, then jumped by 50.06% to 10.69 in 2024, then surged by 241.28% to 15.11 in 2025, then sank by 150.54% to 7.63 in 2026.
- Business Quant data shows INSM's Interest Coverage Ratio at 7.63 in Q1 2026, 15.11 in Q4 2025, and 17.96 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -55.73 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.08 |
| Mar 31, 2026 | -7.63 |
| Dec 31, 2025 | 15.11 |
| Sep 30, 2025 | -17.96 |
| Jun 30, 2025 | -14.73 |
| Mar 31, 2025 | -11.50 |
| Dec 31, 2024 | -10.69 |
| Sep 30, 2024 | -10.14 |
| Jun 30, 2024 | -13.58 |
| Mar 31, 2024 | -6.91 |
| Dec 31, 2023 | -21.41 |
| Sep 30, 2023 | -7.28 |
| Jun 30, 2023 | -11.42 |
| Mar 31, 2023 | -7.41 |
| Dec 31, 2022 | -9.21 |
| Sep 30, 2022 | -38.08 |
| Jun 30, 2022 | -26.31 |
| Mar 31, 2022 | -27.30 |
| Dec 31, 2021 | -8.73 |
| Sep 30, 2021 | -9.21 |